🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Singapore / NCT06775132
Active, not recruiting Observational

Associations Between Dietary Intake and Cardiometabolic and Gut Microbiota Outcomes

NCT06775132 · tracked via the Priya Life Science Singapore tracker
Phase
Observational
Started
2025-02-03
Last updated
2026-08-05

Condition(s) studied

Cardiometabolic Risk FactorsSkin ConditionCognitive Ability, GeneralSleep QualityGut-Microbiota

Study summary

This cross-sectional study aims to investigate the associations between dietary intake, cardiometabolic health markers, and gut microbiota composition in Singapore adults.

Eligibility

Sex
ALL
Min age
21 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Able to give informed consent 2. Adults 21-80 years old 3. English-literate 4. Have venous access sufficient to allow for blood sampling as per the protocol 5. No drastic change of diet for the past 1 year 6. If taking medication, has been consistently taking antihypertensive/cholesterol-lowering/type-2 diabetic medication for more than 5 years prior to starting the study. Exclusion Criteria: 1. Taking dietary supplements and fermented foods, which may impact the gut microbiota (e.g. antibiotics, prebiotics, probiotics, yogurt, kimchi) 2 months before starting the 1st study visit only. 2. Taking dietary supplements or medications, which may impact sleep outcomes (e.g. Nutritional Shakes (e.g. Ensure), tryptophan, 5-hydroxytryptophan or melatonin supplementations) 1 month before starting the study. 3. Taking dietary supplements which may impact the eye outcomes (e.g. Vitamin A, vitamin A-containing multivitamin) 2 months before starting the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
National University of Singapore Singapore Singapore

More National University of Singapore trials in Singapore

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06775132 on ClinicalTrials.gov ↗ ← All trials in Singapore